JP2016525560A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016525560A5 JP2016525560A5 JP2016530509A JP2016530509A JP2016525560A5 JP 2016525560 A5 JP2016525560 A5 JP 2016525560A5 JP 2016530509 A JP2016530509 A JP 2016530509A JP 2016530509 A JP2016530509 A JP 2016530509A JP 2016525560 A5 JP2016525560 A5 JP 2016525560A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- seq
- use according
- sequence
- cell binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13306119 | 2013-08-02 | ||
| EP13306119.2 | 2013-08-02 | ||
| PCT/EP2014/066345 WO2015014879A1 (en) | 2013-08-02 | 2014-07-30 | Use of anti-muc1 maytansinoid immunoconjugate antibody for the treatment of solid tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016525560A JP2016525560A (ja) | 2016-08-25 |
| JP2016525560A5 true JP2016525560A5 (enExample) | 2017-07-13 |
Family
ID=49036539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530509A Abandoned JP2016525560A (ja) | 2013-08-02 | 2014-07-30 | 固形腫瘍を処置するための抗−Ｍｕｃ１メイタンシノイドイムノコンジュゲート抗体の使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160347856A1 (enExample) |
| EP (1) | EP3027218A1 (enExample) |
| JP (1) | JP2016525560A (enExample) |
| KR (1) | KR20160035600A (enExample) |
| CN (1) | CN105592861A (enExample) |
| AU (1) | AU2014298514A1 (enExample) |
| CA (1) | CA2919932A1 (enExample) |
| EA (1) | EA201690321A1 (enExample) |
| IL (1) | IL243843A0 (enExample) |
| MX (1) | MX2016001541A (enExample) |
| TW (1) | TW201605479A (enExample) |
| WO (1) | WO2015014879A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA40539A (fr) * | 2014-09-02 | 2016-03-10 | Immunogen Inc | Procédés de formulation de compositions de conjugués anticorps-médicaments |
| GB201506388D0 (en) * | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Cancer Res Technology Ltd And Howard Philip W | Site-specific antibody-drug conjugates |
| WO2017194568A1 (en) | 2016-05-11 | 2017-11-16 | Sanofi | Treatment regimen using anti-muc1 maytansinoid immunoconjugate antibody for the treatment of tumors |
| CN105997942B (zh) * | 2016-06-24 | 2019-01-29 | 浙江大学 | 一种人血清白蛋白负载美登素类药物的纳米颗粒及其制备方法和应用 |
| JP7162011B2 (ja) * | 2017-01-18 | 2022-10-27 | ナノクルーズ・ファーマシューティカル・リミテッド | 癌糖ペプチドに対するモノクローナルおよびヒト化抗体 |
| US11236059B2 (en) * | 2017-08-09 | 2022-02-01 | Helmholtz-Zentrum Fuer Infektionsforschung Gmbh | Targeted cytotoxic ratjadone derivatives and conjugates thereof |
| EP3794042B1 (en) | 2018-05-18 | 2024-03-27 | Daiichi Sankyo Co., Ltd. | Anti-muc1- exatecan antibody-drug conjugate |
| BR112021008526A2 (pt) * | 2018-11-02 | 2021-08-10 | Cytomx Therapeutics, Inc. | anticorpos anti-cd166 ativáveis e métodos de uso dos mesmos |
| KR20250160368A (ko) * | 2022-03-23 | 2025-11-12 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 뮤신-1에 특이적인 항체 접합체 및 그의 사용 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1291898A (zh) * | 1998-02-25 | 2001-04-18 | 若素制药株式会社 | 用于角膜上皮疾病的药物 |
| EA014640B1 (ru) * | 2003-07-21 | 2010-12-30 | Иммьюноджен, Инк. | Антитело или его эпитоп-связывающий фрагмент, которые связываются с гликотопом са6, и способы их применения |
| EA020130B9 (ru) * | 2005-08-22 | 2014-10-30 | Иммьюноджен, Инк. | Специфичное к антигену са6 антитело, содержащий его цитотоксический конъюгат и способы применения конъюгата |
| WO2010126552A1 (en) * | 2009-04-30 | 2010-11-04 | Immunogen, Inc. | Potent cell-binding agent drug conjugates |
| CN102596922A (zh) * | 2009-10-06 | 2012-07-18 | 免疫基因公司 | 有效的缀合物和亲水性连接体 |
-
2014
- 2014-07-30 MX MX2016001541A patent/MX2016001541A/es unknown
- 2014-07-30 WO PCT/EP2014/066345 patent/WO2015014879A1/en not_active Ceased
- 2014-07-30 EA EA201690321A patent/EA201690321A1/ru unknown
- 2014-07-30 KR KR1020167004778A patent/KR20160035600A/ko not_active Withdrawn
- 2014-07-30 EP EP14747592.5A patent/EP3027218A1/en active Pending
- 2014-07-30 CN CN201480054398.5A patent/CN105592861A/zh active Pending
- 2014-07-30 CA CA2919932A patent/CA2919932A1/en not_active Withdrawn
- 2014-07-30 JP JP2016530509A patent/JP2016525560A/ja not_active Abandoned
- 2014-07-30 US US14/909,671 patent/US20160347856A1/en not_active Abandoned
- 2014-07-30 AU AU2014298514A patent/AU2014298514A1/en not_active Withdrawn
- 2014-08-01 TW TW103126492A patent/TW201605479A/zh unknown
-
2016
- 2016-01-31 IL IL243843A patent/IL243843A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7425026B2 (ja) | フタロシアニン色素コンジュゲートおよびその保存法 | |
| JP7585230B2 (ja) | バイパラトピックＦＲ－α抗体及びイムノコンジュゲート | |
| CN111587124B (zh) | Ror1抗体免疫缀合物 | |
| JP2024522312A (ja) | 抗体薬物複合体の調製方法および使用 | |
| ES2992591T3 (en) | Compositions, combinations and related methods for photoimmunotherapy | |
| CN106999604B (zh) | 用于配制抗体药物缀合物组合物的方法 | |
| RU2016129894A (ru) | Ковалентно связанные конъюгаты хеликар-антитело против хеликара и их применения | |
| JP2014515036A5 (enExample) | ||
| JP2016502504A5 (enExample) | ||
| JP2017535246A5 (enExample) | ||
| JP2016531915A5 (enExample) | ||
| JP2015534580A5 (enExample) | ||
| CN112512583B (zh) | 酞菁染料偶联物组合物 | |
| RU2018111205A (ru) | Терапевтические комбинации, содержащие анти-folr1 иммуноконъюгаты | |
| RU2019110070A (ru) | Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения | |
| JP2016538318A5 (enExample) | ||
| HRP20240917T1 (hr) | Režimi doziranja anti-folr1 imunokonjugata | |
| CA2858133A1 (en) | Uses of immunoconjugates targeting cd138 | |
| Lidický et al. | Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab | |
| KR102544135B1 (ko) | c-Kit을 표적으로 하는 면역접합체 | |
| WO2025099152A1 (en) | Antibodies and molecular conjugates thereof targeting upar | |
| WO2024213081A1 (zh) | 抗体药物偶联物在制备预防和/或治疗癌症的药物中的用途 | |
| HK40048277A (en) | Phthalocyanine dye conjugates and their storage | |
| BR112019027448B1 (pt) | Imunoconjugado compreendendo um anticorpo conjugado a uma porção de fármaco citotóxica, composição farmacêutica e uso dos mesmos | |
| WO2018174005A1 (ja) | 医薬 |